|
Press Release: Seventh Asia Pac Pharma and Medical Device Compliance Congress Features George "Ren" McEachern, Supervisory Special Agent, International Corruption Squad, FBI on Outreach from the Anti Bribery and Corruption Investigating Agencies
|
- Sponsored by Asia Pacific Healthcare Industry Compliance Team
- Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
- September 13 - 15, 2017
- InterContinental Shanghai, Shanghai, China
- www.AsianPharmaCongress.com
PRESS RELEASE
Phone: 800-503-6498
Email: registration@hcconferences.com
Website: www.AsianPharmaCongress.com
|
SPEAKER PRESENTATION PROPOSALS
|
Speaker/Presentation Proposals for the Asia Pacific Pharma Congress May Be Submitted Through Our Online Form.
- Click Here -
|
FEATURING SAFEGUARDING AGAINST BRIBERY AND CORRUPTION: OUTREACH FROM THE INVESTIGATING AGENCIES BY
|
|
George "Ren" McEachern, CFE, CAMS, Supervisory Special Agent, International Corruption Squad, US Federal Bureau of Investigation, Washington, DC, USA
|
|
|
SHANGHAI, CHINA -- PHARMA UPDATE NEWS SERVICE -- JUNE 6, 2017: The Seventh Asia Pacific Pharmaceutical and Medical Device Compliance Congress, www.AsianPharmaCongress.com, ill be held September 13 - 15, 2017 at the InterContinental Shanghai in Shanghai, China.
|
CO CHAIRS
|
Masood Ahmed
Vice President, Regional Compliance Officer Asia & JPAC, Sanofi Group, Singapore |
Maija Burtmanis, LLB/BSc LLM
Regional Compliance Director, Japan / Asia Pacific, Shire, Former Healthcare CO, Asia Pacific Medical Sciences, Johnson & Johnson, Former Associate GC, Alcon Russia, Former Asia Pacific, Country CO, Novartis SG, Singapore |
Gareth Lee
Vice President, Legal and Compliance, Asia Pacific, Cardinal Health, Former General Counsel & Head of Compliance, Asia Pacific, Allergan, Singapore
|
Maria “Maru” Quindimil, MBA
APAC Ethics and Compliance Lead, UCB Pharma, Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Shanghai, China |
Rhys Tee
Director, Compliance and Privacy, ASPAC, Ortho Clinical Diagnostics, Former Compliance Director, Asia, Abbott Laboratories (Singapore) Pte. Ltd., Former Associate Director, Compliance (APAC), Allergan, Singapore
|
|
FEATURED FACULTY
|
Ted Acosta, Esq.
Americas Vice Chair, Risk Management, EY, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France |
Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma PLC, Executive Committee, Pharmaceutical Compliance Forum, Former VP and CCO, Dendreon, Former Associate GC and ED of Compliance, Seattle Genetics, Chicago, IL, USA |
Ann Beasley, JD
Director, Healthcare and Life Sciences Disputes, Compliance & Investigations, Navigant Consulting, Former Chief Compliance Officer, Biogen, Former Global Compliance Officer, Novartis, Boston, MA, USA
|
Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY, USA |
Praween Chantanakomes, JD
Associate, Baker & McKenzie, Bangkok, Thailand |
Chi Chen
Fraud Investigation & Dispute Services, EY, Shanghai, China
|
Hwa Soo Chung, JD, MPA
Chair, Health Practice Group, Kim and Chang, Seoul, South Korea |
Campbell Clark, LLB, MJ
Chief Ethics and Compliance Officer, Asia Pacific, Medtronic, Covidien Private Limited, Chair, Legal, Ethics and Compliance Committee, Asia Pacific Medical Technology Association (APACMed), Singapore |
Mike Dethick, LLB
Managing Director, R&D-Based Pharmaceutical Association Committee, Beijing, China
|
Karen Eryou
Head, Ethics AND Compliance Programs, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium |
Giuseppe Falbo
Regional Compliance Director (APAC and Russia), Alcon, A Novartis Division, Former Business Practices Officer (Asia, Middle East, Africa, Latin America), Novartis International AG, Singapore |
Chris Fordham
Managing Partner, Asia Pacific Area, Fraud Investigation, and Dispute Services, EY, Hong Kong
|
Luca Genovese, AMID
Researcher, Access to Medicine Foundation, Amsterdam, Netherlands |
Kent Kedl, MA
Senior Partner, Control Risks, Former Vice President and General Manager, Technomic Asia, Shanghai, China |
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA
|
Patrik Kronig
Head of Compliance Pharma Asia Pacific, Roche, Singapore |
Rachel B. Layburn, MBA
Partner in Charge, Forensic and Investigations Practice, KPMG China, Beijing, China |
Lei Li, LLM
Partner, Sidley Austin, Former Third Secretary, Ministry of Commerce, People’s Republic of China, Beijing, China
|
Michael K. Loucks, JD
Partner, Skadden Arps LLP, Former Acting United States Attorney, District of Massachusetts, US Department of Justice, Washington, DC, USA |
Angela Main, MA
Vice President, Global Chief Compliance Officer and Associate General Counsel, Asia Pacific , Zimmer Biomet, Former Senior Legal Counsel, Covidien Pte Ltd, Singapore |
George "Ren" McEachern, CFE, CAMS
Supervisory Special Agent, International Corruption Squad, US Federal Bureau of Investigation, Washington, DC, USA
|
Christopher L. White, JD
Chief Operating Officer General Counsel, Advanced Medical Technology Association (AdvaMed), Washington, DC, USA |
Chae Sing Wong
Head of Regional Compliance (APAC, MEA, LATM), Mundipharma Pte Ltd, Former Compliance Director, Asia, ANZ and Japan, Baxalta, Former Compliance Director Asia Area, AstraZeneca, Singapore |
Carol Wu
Third Party Audit, Asia, Global Ethics & Compliance, GSK, Former Manager, Ethics & Compliance- China, Hospira, Former Senior Compliance Manager, AstraZeneca, Shanghai, China
|
Chen Yang, LLB, LLM
Partner and Head, China Life Sciences Practice, Sidley Austin LLP, Former Legislative Official, Bureau of Legislative Affairs, Chinese State Council, Beijing, China |
Xi Zhang, LLM, PhD Law
Vice President & General Counsel Greater China, Bayer (China) Limited, Former General Counsel Asia, Celanese, Shanghai, China
|
|
2017-2018 GLOBAL PHARMA COMPLIANCE CONGRESSES
|
|
ELEVENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by Pharmaceutical Compliance Forum (PCF)
May 15 - 17, 2017
Lisbon Marriott Hotel
Lisbon, Portugal
www.International PharmaCongress.com
|
|
SEVENTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
September 13 - 15, 2017
InterContinental Shanghai, Shanghai, China
www.Asian PharmaCongress.com
|
|
EIGHTEENTH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 6 - 8, 2017
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
|
|
INDIAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by International Society of Healthcare Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
Spring 2018
Mumbai, India
Coming Soon
|
|
|
|
|
SPONSORED BY:
|
The Asia Pacific Healthcare Industry Compliance Team is an ad hoc, voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel who meet quarterly to discuss legal and compliance issues and best practices.
|
COSPONSORED BY:
|
The International Society of Healthcare Ethics and Compliance Professionals (ETHICS) is a forum for open dialogue and exchange among Compliance and Ethics professionals in the Healthcare industry. Association's activities are developed around the four following pillars, sustained by one transverse and permanent objective: support professionals in Compliance and Ethics in Healthcare industry to develop and better manage their role and duties -- without any sort of commercial benefit for the Association or any of its members.
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.
|
GRANTORS:
|
BRONZE
|
|
STAY CONNECTED
|
Tweet using #PharmaCongress
|
ASIA PACIFIC PHARMA CONGRESS IS
|
|
ONSITE ATTENDANCE
|
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; faculty interaction
|
SEVENTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE ETHICS AND COMPLIANCE CONGRESS PLANNING COMMITTEE
|
CO-CHAIRS
|
Masood Ahmed
Vice President, Regional Compliance Officer Asia & JPAC, Sanofi Group, Singapore
Maija Burtmanis, LLB/BSc LLM
Regional Compliance Director, Japan/Asia Pacific, Shire, Former Healthcare CO, Asia Pacific, Medical Sciences, Johnson & Johnson, Former Associate GC, Alcon Russia, Former Asia Pacific, Country CO, Novartis SG, Singapore
Gareth Lee
Vice President, Legal and Compliance, Asia Pacific, Cardinal Health, Former General Counsel & Head of Compliance, Asia Pacific, Allergan, Singapore
Maria "Maru" Quindimil, MBA
APAC Ethics and Compliance Lead, UCB Pharma, Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Shanghai, China
Rhys Tee
Director, Compliance and Privacy, ASPAC, Ortho Clinical Diagnostics, Former Compliance Director, Asia, Abbott Laboratories Pte. Ltd., Former Associate Director, Compliance (APAC), Allergan, Singapore
|
MEMBERS
|
Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma PLC, Executive Committee, Pharmaceutical Compliance Forum, Former VP and CCO, Dendreon, Former Associate GC and ED of Compliance, Seattle Genetics, Chicago, IL, USA
Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY, USA
Tom Chan, JD, LLM
Head of Legal, Greater China, Takeda (China) Holdings Co., LTD, Shanghai, China
Campbell Clark
Chief Ethics and Compliance Officer, Asia Pacific, Medtronic, Covidien Private Limited, Singapore
Abigail Enriquez
Assistant Business Development Manage, Baker & McKenzie, Manilla, Philippines
Karen Eryou
Head, Ethics and Compliance Programs, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium
Giuseppe Falbo
Regional Compliance Director (APAC and Russia), Alcon, A Novartis Division, Former Business Practices Officer (Asia, Middle East, Africa, Latin America), Novartis International AG, Singapore
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA
Patrik Kronig
Head of Compliance Pharma Asia Pacific, Roche, Singapore
Lei Li, LLM
Partner, Sidley Austin, Former Third Secretary, Ministry of Commerce, People’s Republic of China, Beijing, China
Sabina Sudan, LLB, LLM
Legal/International Compliance and Risk Management Professional (Singapore / New Delhi, India), Former Vice President and Compliance Officer, Pharma, EJEMAP, GSK, Former Director, Compliance, APAC, Abbott Labs, Delhi, India
Albert van Maaren, MSc
Regional Compliance Officer APAC, Group Compliance, Merck Pte. Ltd., Singapore
Emmanuel Vignal
Partner and Greater China Leader, Fraud Investigation & Dispute Services, EY, Shanghai, China
Jonathan Shun Wah, PCLL
Senior Director, China Investigations Lead, Pfizer, Hong Kong
Chae Sing Wong
Head of Regional Compliance (APAC, MEA, LATM), Mundipharma Pte Ltd, Former Compliance Director, Asia, ANZ and Japan, Baxalta, Former Compliance Director Asia Area, AstraZeneca, Singapore
Hideki Yamanaka
Head of Ethics and Compliance, Japan and Vice President, Astellas Pharma, Tokyo, Japan
Xi Zhang, LLM, PhD Law
Vice President & General Counsel Greater China, Bayer (China) Limited, Former General Counsel Asia, Celanese, Shanghai, China
|
|
|
|